DUSA Pharmaceuticals Reports Fourth-Quarter and Year-End 2006 Financial Results

WILMINGTON, MASSACHUSETTS -- (MARKET WIRE) -- March 16, 2007 -- DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today reported financial results for the fourth quarter and full year ended December 31, 2006.
MORE ON THIS TOPIC